Custom Synthesis

Andrographolide Analogue 3a.1 View larger

Andrographolide Analogue 3a.1

AOB16342

Molarity Calculation Cart®

HOW TO ORDER

$0.00

More info

Novel anticancer agent against metastatic Castration resistance and neuroendocrine variant prostate cancers (mCRPC/NEPC), exhibiting synergistic anticancer effect in combination with standard therapy docetaxel and cabazitaxel in mCRPC/NEPC, upregulating Heat Shock proteins and downregulating MAT2A-mediated cell migration and invasion